M&A TRANSACTION · 2023
Bluebird Home Health / Hospice acquired by Pennant Group, Inc.
$6.4M· 1.00x revenue
Target
Bluebird Home Health / Hospice
Acquirer
Pennant Group, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$6.2M
EBITDA
—
Deal Value
$6.4M
EV/EBITDA
—
Context
This $6.4M acquisition of Bluebird Home Health / Hospice by Pennant Group, Inc. sits in the home health sub-vertical. Pennant Group, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price home health businesses on our Home Health strategic buyer-pool page.
Source
Data sourced from SEC filings and cost reports. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own home health
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Bluebird Home Health / Hospice acquisition.